Interestingly, PDH activity was not reduced in hearts from myriocin treated DIO mice, once more suggesting that SPT I inhibition improves obesity-induced impairments on myocardial glucose utilization. The gene discussed is PDP1; the disease is obesity due to melanocortin 4 receptor deficiency.